Abstract
Currently, entomopathogenic nematodes occupy the second largest segment of the bioinsecticide market in the developed countries, being used against a broad spectrum of insect pests. In Latin America, there is no company producing nematodes by the in vitro process, in a way so the company can explore the real potential market for the using of these agents. The Instituto Biológico, in a par…